Therapeutic antibody drugs based on targeted molecular epitopes
- At: 2014 FIP Congress in PSWC, Melbourne (Australia)
- Type: Presentation
- By: CHEN, Zhi-Nan (The Fourth Military Medical University, Cell Engineering Research Center and Department of Cell Biology, Xi'an, China)
Monoclonal antibodies (mAbs) have been widely applied in the diagnosis and treatment of human diseases, such as cancer, transplant rejection, and autoimmune diseases, with inherent advantages such as specificity for target, low toxicity relative to small-molecule drugs, long half-life in serum, and the capacity for multiple cytotoxic mechanisms of.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.